Jin G. Sheng

5.9k total citations · 1 hit paper
46 papers, 5.0k citations indexed

About

Jin G. Sheng is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Jin G. Sheng has authored 46 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 23 papers in Molecular Biology and 20 papers in Neurology. Recurrent topics in Jin G. Sheng's work include Alzheimer's disease research and treatments (29 papers), Neuroinflammation and Neurodegeneration Mechanisms (17 papers) and S100 Proteins and Annexins (16 papers). Jin G. Sheng is often cited by papers focused on Alzheimer's disease research and treatments (29 papers), Neuroinflammation and Neurodegeneration Mechanisms (17 papers) and S100 Proteins and Annexins (16 papers). Jin G. Sheng collaborates with scholars based in United States, China and United Kingdom. Jin G. Sheng's co-authors include W. Sue T. Griffin, Robert E. Mrak, Robert E. Mrak, Gareth W. Roberts, David I. Graham, Linda J. Van Eldik, G.W. Roberts, Steve Gentleman, J.E. McKenzie and M.C. Royston and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and Annals of the New York Academy of Sciences.

In The Last Decade

Jin G. Sheng

46 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

1998 598 citations W. Sue T. Griffin, Jin G. Sheng et al. profile →

Peers

Countries citing papers authored by Jin G. Sheng

Since Specialization

Citations

This map shows the geographic impact of Jin G. Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin G. Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin G. Sheng more than expected).

Fields of papers citing papers by Jin G. Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin G. Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin G. Sheng. The network helps show where Jin G. Sheng may publish in the future.

Co-authorship network of co-authors of Jin G. Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jin G. Sheng. A scholar is included among the top collaborators of Jin G. Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin G. Sheng. Jin G. Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liquiritin Relieves LPS-Induced Endometritis Through Activating Keap1/Nrf2/HO-1 Signaling Pathway 2023 ·Revista Brasileira de Farmacognosia ·Jin G. Sheng, (unknown), (unknown), (unknown)	2
2	An Investigation on Main Traits of Transgenic Silkworm Overexpressing Bmlipase-1 2012 ·Canye kexue ·Jin G. Sheng	3
3	Reversion of MDR of HL60/ADR and MCF-7/ADR with curcumin in vitro. 2010 ·Jin G. Sheng, (unknown), Man Zhang	1
4	Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease 2006 ·Neurobiology of Disease ·Joel A. Saydoff, Rolando A.G. Garcia, Susan Browne, Liansheng Liu, Jin G. Sheng, (unknown), Zhongyi Hu, Sylvain Cardin, Alexis González, Reid W. von Borstel, (unknown), Hermann Burr, M. Flint Beal	23
5	Correlation Migration of Scattered Teleseismic Body Waves With Application to the 1993 Cascadia Experiment 2003 ·AGU Fall Meeting Abstracts ·Robert L. Nowack, (unknown), Gerard T. Schuster, Jin G. Sheng	2
6	Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice 2003 ·Neurobiology of Disease ·Jin G. Sheng	330
7	Overexpression of the Neuritotrophic Cytokine S100β Precedes the Appearance of Neuritic β‐Amyloid Plaques in APPV717F Mice 2000 ·Journal of Neurochemistry ·Jin G. Sheng, Robert E. Mrak, Kelly R. Bales, Barbara Cordell, Steven M. Paul, Richard A. Jones, S Woodward, Xue Zhou, (unknown), W. Sue T. Griffin	67
8	Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo 2000 ·Experimental Neurology ·Jin G. Sheng, (unknown), Richard A. Jones, W. Sue T. Griffin, Robert E. Mrak	120
9	Increased lnterleukin-1β Converting Enzyme Expression and Activity in Alzheimer Disease 1999 ·Journal of Neuropathology & Experimental Neurology ·Shaojun Zhu, Jin G. Sheng, Richard A. Jones, (unknown), Xue Zhou, Robert E. Mrak, W. Sue T. Griffin	40
10	Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’ 1999 ·Molecular Psychiatry ·Craig N. Karson, Robert E. Mrak, (unknown), William Q. Sturner, Jin G. Sheng, W. Sue T. Griffin	177
11	Progressive Neuronal DNA Damage Associated with Neurofibrillary Tangle Formation in Alzheimer Disease 1998 ·Journal of Neuropathology & Experimental Neurology ·Jin G. Sheng, Robert E. Mrak, W. Sue T. Griffin	44
12	Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms 1997 ·Acta Neuropathologica ·Jin G. Sheng, Robert E. Mrak, W. Sue T. Griffin	158
13	Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease 1996 ·Neurobiology of Aging ·Jin G. Sheng, Robert E. Mrak, Cynthia R. Rovnaghi, Ewa Kozłowska, Linda J. Van Eldik, W. Sue T. Griffin	131
14	Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression 1996 ·Neuropathology and Applied Neurobiology ·Jin G. Sheng, (unknown), W. Sue T. Griffin	38
15	Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution 1995 ·Neuropathology and Applied Neurobiology ·Jin G. Sheng, Robert E. Mrak, W. Sue T. Griffin	149
16	Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease 1995 ·Journal of Neuropathology & Experimental Neurology ·W. Sue T. Griffin, Jin G. Sheng, Gareth W. Roberts, Robert E. Mrak	440
17	Microglial interleukin-lα expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression 1994 ·Neuroscience Letters ·W. Sue T. Griffin, Jin G. Sheng, Stephen M. Gentleman, David I. Graham, Robert E. Mrak, Gareth W. Roberts	138
18	Increased Neuronal β‐Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin‐1α Immunoreactivity 1994 ·Journal of Neurochemistry ·Jin G. Sheng, Frederick A. Boop, Robert E. Mrak, W. Sue T. Griffin	159
19	Trophic Factor Production by Reactive Astrocytes in Injured Brain 1993 ·Annals of the New York Academy of Sciences ·Joan P. Schwartz, Jin G. Sheng, (unknown), Susumu Shirabe, Nobuyoshi Nishiyama	21
20	Dopaminergic Neuronal Sprouting and Behavioral Recovery in Hemi-Parkinsonian Rats after Implantation of Amnion Cells 1993 ·Experimental Neurology ·Jin G. Sheng, Lisa M. McShane, Robert J. Plunkett, Alex C. Cummins, Edward H. Oldfield, Irwin J. Kopin, Meg A. Palmatier	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact